News

RTL downgraded to “neutral” by J.P. Morgan on SkyD risks, forecast cuts
Investing.com -- J.P. Morgan has downgraded RTL (H: RRTL) to “neutral” from “overweight,” citing strategic and financial ...
Uniqlo parent warns of prices hikes as tariff pressures mount
Investing.com - Heightened U.S. tariffs are expected to dent the American operations of Uniqlo-owner Fast Retailing, the ...
Goldman Sachs upgrades McDonald’s on market share push
Investing.com -- Goldman Sachs upgraded McDonald’s (NYSE: MCD) to Buy on expectations the fast-food giant will regain market ...
Diligent Robotics hires ex-Cruise executives to expand beyond healthcare
Investing.com -- Diligent Robotics has appointed two former Cruise executives to key leadership positions as the humanoid robot maker prepares to expand beyond hospital logistics into broader ...
AXT stock falls after lowering Q2 revenue guidance on export challenges
Investing.com -- AXT, Inc. (NASDAQ: AXTI) stock fell 11.4% after the compound semiconductor substrates manufacturer lowered its second quarter revenue guidance due to slower-than-expected export ...
PDS Biotechnology stock rises after trial meets criteria for expansion
Investing.com -- PDS Biotechnology Corp (NASDAQ: PDSB) stock rose 3.8% after the company announced that its clinical trial for metastatic colorectal cancer treatment has met pre-set criteria for ...
Allurion Technologies stock rises on Canadian distribution partnership
Investing.com -- Allurion Technologies Inc (NYSE: ALUR) stock rose 2.9% following the announcement of a strategic distribution partnership with Minogue Medical Inc., a Canadian medical device company ...
U.K. REITs cut to “underperform” as debt risks weigh on returns: Jefferies
Investing.com -- Jefferies has downgraded Land Securities (LON: LAND) and British Land (LON: BLND) to “underperform,” citing structural debt risks and weakening returns across the U.K. REIT sector.
Cognition Therapeutics stock soars after FDA meeting on Alzheimer’s drug
Investing.com -- Cognition Therapeutics Inc (NASDAQ: CGTX) stock surged 75% following the company’s end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) regarding its Alzheimer’s ...
Grok 4 is here and analyst says ’don’t bet against Elon’
“Don’t bet against Elon,” the analyst said in a note, adding that xAI appears close to matching DeepSeek in both innovation and GPU efficiency. The company is scaling reinforcement learning (RL) ...
Initial jobless claims fall, beating expectations and signaling strengthened economy
The drop in initial jobless claims is likely to be seen as a bullish sign for the USD. Economists often interpret a lower than expected jobless claims figure as a positive sign for the U.S. dollar, as ...
Byrna Technologies shares rise as Q2 earnings beat estimates
The less-lethal security solutions provider posted adjusted earnings of $0.10 per share for the quarter ended May 31, 2025, exceeding analyst estimates of $0.08 per share. Revenue surged 41% YoY to a ...